ACADIA PHARMACEUTICALS INC - Common Stock (ACAD)
CUSIP: 004225108
Q2 2020 13F Holders as of 30 Jun 2020
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 170,450,287
- Total 13F shares
- 152,670,605
- Share change
- -1,149,065
- Total reported value
- $7,396,593,388
- Put/Call ratio
- 108%
- Price per share
- $48.47
- Number of holders
- 292
- Value change
- -$42,512,386
- Number of buys
- 155
- Number of sells
- 119
Quarterly Holders Quick Answers
What is CUSIP 004225108?
CUSIP 004225108 identifies ACAD - ACADIA PHARMACEUTICALS INC - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 004225108:
Top shareholders of ACAD - ACADIA PHARMACEUTICALS INC - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BAKER BROS. ADVISORS LP |
13F
|
Company |
25%
|
41,904,586
|
$1,770,469,000 | — | 31 Mar 2020 | |
| FMR LLC |
13F
|
Company |
12%
|
20,290,897
|
$857,291,000 | — | 31 Mar 2020 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
6.9%
|
11,827,905
|
$499,729,000 | — | 31 Mar 2020 | |
| VANGUARD GROUP INC |
13F
|
Company |
6.4%
|
10,983,037
|
$464,033,000 | — | 31 Mar 2020 | |
| BlackRock Finance, Inc. |
13F
|
Company |
5.9%
|
10,136,110
|
$428,249,000 | — | 31 Mar 2020 | |
| STATE STREET CORP |
13F
|
Company |
2.4%
|
4,042,296
|
$170,787,000 | — | 31 Mar 2020 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
2.2%
|
3,701,355
|
$156,382,000 | — | 31 Mar 2020 | |
| HealthCor Management, L.P. |
13F
|
Company |
1.3%
|
2,230,474
|
$94,238,000 | — | 31 Mar 2020 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
1.2%
|
2,005,744
|
$84,743,000 | — | 31 Mar 2020 | |
| GREAT POINT PARTNERS LLC |
13F
|
Company |
1.2%
|
1,995,747
|
$84,320,000 | — | 31 Mar 2020 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1%
|
1,728,070
|
$73,010,000 | — | 31 Mar 2020 | |
| Palo Alto Investors LP |
13F
|
Company |
0.96%
|
1,631,524
|
$68,932,000 | — | 31 Mar 2020 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.93%
|
1,592,016
|
$67,260,000 | — | 31 Mar 2020 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.88%
|
1,497,509
|
$63,270,000 | — | 31 Mar 2020 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
0.87%
|
1,489,902
|
$62,948,000 | — | 31 Mar 2020 | |
| FIRST TRUST ADVISORS LP |
13F
|
Company |
0.84%
|
1,436,349
|
$60,686,000 | — | 31 Mar 2020 | |
| PICTET ASSET MANAGEMENT LTD |
13F
|
Company |
0.84%
|
1,426,382
|
$60,264,000 | — | 31 Mar 2020 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.82%
|
1,396,477
|
$59,001,000 | — | 31 Mar 2020 | |
| FRONTIER CAPITAL MANAGEMENT CO LLC |
13F
|
Company |
0.8%
|
1,355,455
|
$57,268,000 | — | 31 Mar 2020 | |
| NORGES BANK |
13F
|
Company |
0.79%
|
1,341,504
|
$56,679,000 | — | 31 Mar 2020 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.76%
|
1,290,129
|
$54,508,000 | — | 31 Mar 2020 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.75%
|
1,283,497
|
$54,228,000 | — | 31 Mar 2020 | |
| Polar Capital LLP |
13F
|
Company |
0.75%
|
1,274,366
|
$53,842,000 | — | 31 Mar 2020 | |
| Artisan Partners Limited Partnership |
13F
|
Company |
0.74%
|
1,264,168
|
$53,411,000 | — | 31 Mar 2020 | |
| FRED ALGER MANAGEMENT, LLC |
13F
|
Company |
0.66%
|
1,127,772
|
$47,648,000 | — | 31 Mar 2020 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.64%
|
1,097,306
|
$46,362,000 | — | 31 Mar 2020 | |
| Rock Springs Capital Management LP |
13F
|
Company |
0.6%
|
1,025,000
|
$43,306,000 | — | 31 Mar 2020 | |
| EAGLE ASSET MANAGEMENT INC |
13F
|
Company |
0.6%
|
1,017,487
|
$42,988,000 | — | 31 Mar 2020 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.54%
|
927,435
|
$39,184,000 | — | 31 Mar 2020 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.49%
|
842,958
|
$35,615,000 | — | 31 Mar 2020 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.48%
|
826,661
|
$34,927,000 | — | 31 Mar 2020 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.46%
|
775,602
|
$32,769,186 | — | 31 Mar 2020 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.4%
|
676,590
|
$28,586,000 | — | 31 Mar 2020 | |
| CARILLON TOWER ADVISERS, INC. |
13F
|
Company |
0.42%
|
715,382
|
$28,085,897 | — | 31 Mar 2020 | |
| Fairmount Funds Management LLC |
13F
|
Company |
0.35%
|
603,517
|
$25,499,000 | — | 31 Mar 2020 | |
| Hood River Capital Management LLC |
13F
|
Company |
0.35%
|
590,364
|
$24,943,000 | — | 31 Mar 2020 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.34%
|
579,486
|
$24,485,000 | — | 31 Mar 2020 | |
| Invesco Ltd. |
13F
|
Company |
0.34%
|
573,626
|
$24,235,000 | — | 31 Mar 2020 | |
| WESTFIELD CAPITAL MANAGEMENT CO LP |
13F
|
Company |
0.3%
|
509,885
|
$21,543,000 | — | 31 Mar 2020 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.3%
|
506,603
|
$21,404,000 | — | 31 Mar 2020 | |
| PEREGRINE CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.24%
|
408,954
|
$17,278,000 | — | 31 Mar 2020 | |
| Boxer Capital, LLC |
13F
|
Company |
0.22%
|
370,000
|
$15,633,000 | — | 31 Mar 2020 | |
| Avidity Partners Management LP |
13F
|
Company |
0.21%
|
357,000
|
$15,083,000 | — | 31 Mar 2020 | |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC |
13F
|
Company |
0.2%
|
337,000
|
$14,232,000 | — | 31 Mar 2020 | |
| EcoR1 Capital, LLC |
13F
|
Company |
0.19%
|
323,889
|
$13,684,000 | — | 31 Mar 2020 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.18%
|
307,846
|
$13,006,000 | — | 31 Mar 2020 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.17%
|
291,404
|
$12,306,000 | — | 31 Mar 2020 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
0.17%
|
286,851
|
$12,120,000 | — | 31 Mar 2020 | |
| Allianz Asset Management GmbH |
13F
|
Company |
0.16%
|
278,727
|
$11,776,000 | — | 31 Mar 2020 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.15%
|
251,085
|
$10,608,000 | — | 31 Mar 2020 |
Institutional Holders of ACADIA PHARMACEUTICALS INC - Common Stock (ACAD) as of Q2 2020
As of 30 Jun 2020,
ACADIA PHARMACEUTICALS INC - Common Stock (ACAD) was held by
292 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
152,670,605 shares.
The largest 10 holders included
BAKER BROS. ADVISORS LP, FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/, VANGUARD GROUP INC, BlackRock Inc., JANUS HENDERSON GROUP PLC, CITADEL ADVISORS LLC, STATE STREET CORP, AMERIPRISE FINANCIAL INC, and D. E. Shaw & Co., Inc..
This page lists
292
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2020 vs Q1 2020 Across Filers
Q1 2020 holders
243
Q2 2020 holders
292
Holder diff
49
| Investor | Q1 2020 Shares | Q2 2020 Shares | Share Diff | Share Chg % | Q1 2020 Value $ | Q2 2020 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.